Moderna share price doubles on melanoma vaccine trial success

All NewsAugust 19, 2026

Company’s melanoma cancer vaccine being developed with Merck

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT